Insight Molecular Diagnostics Inc.
IMDX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001642380
No open-market purchases or sales by Insight Molecular Diagnostics Inc. insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $108.9M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Insight Molecular Diagnostics Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 27 | 30 | +3 |
| Shares | 8.42M | 16.1M | +7.68M (+91.2%) |
| Value | $20.0M | $49.2M | +$29.2M (+145.8%) |
New holders (8)
Institutions that held Insight Molecular Diagnostics Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 48,784 | $149.3K | 0.00% |
| Susquehanna International Group, LLP | 44,806 | $137.1K | 0.00% |
| SG Americas Securities, LLC | 16,585 | $51.0K | 0.00% |
| Millennium Management LLC | 13,404 | $41.0K | 0.00% |
| HRT Financial LP | 10,149 | $31.0K | 0.00% |
| ORG Partners LLC | 450 | $1.35K | 0.00% |
| Larson Financial Group LLC | 125 | $383 | 0.00% |
| Wells Fargo & Company | 3 | $9 | 0.00% |
Sold out (5)
Institutions that held Insight Molecular Diagnostics Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Two Sigma Securities, LLC | 13,215 | $31.5K |
| Ground Swell Capital, LLC | 10,915 | $26.0K |
| Lee Danner & Bass Inc | 1,388 | $3.30K |
| Coppell Advisory Solutions LLC | 10 | $24 |
| Danske Bank A/S | 1 | $2 |